Researchers compared women who took the drug alongside hormone therapy with women who took just the GLP-1 and found that women who took both lost more weight than those just taking the weight loss drug alone
With oral formulations gaining regulatory approvals and commercial traction, advancements in drug delivery represent a critical driver shaping the future growth of this market
(New England Journal of Medicine, 2023)
Eli Lilly's growth rate has been elevated in recent years due to the success of Mounjaro and Zepbound, its GLP-1 drugs that are already generating billions in revenue, and this approval could give it a further boost
It boosts downstream productivity by enabling near-constant processing, and because it requires less resin and fewer buffer components, it can reduce raw material costs by up to 40%
Its the second daily oral medication to treat obesity and other weight-related conditions (Novo Nordisks oral Wegovy was the first) allowing patients to avoid having to give themselves injections